Multicenter retrospective study of cetuximab plus platinum-based chemotherapy for recurrent or metastatic oral squamous cell carcinoma

Souichi Yanamoto,Masahiro Umeda,Mitomu Kioi,Tadaaki Kirita,Tetsuro Yamashita,Hiroyoshi Hiratsuka,Satoshi Yokoo,Hideki Tanzawa,Narikazu Uzawa,Takahiko Shibahara,Yoshihide Ota,Hiroshi Kurita,Masaya Okura,Hiroyuki Hamakawa,Jingo Kusukawa,Iwai Tohnai

Multicenter retrospective study of cetuximab plus platinum-based chemotherapy for recurrent or metastatic oral squamous cell carcinoma

2018

Souichi Yanamoto
Masahiro Umeda
Mitomu Kioi
Tadaaki Kirita
Tetsuro Yamashita
Hiroyoshi Hiratsuka
Satoshi Yokoo
Hideki Tanzawa
Narikazu Uzawa
Takahiko Shibahara
Yoshihide Ota
Hiroshi Kurita
Masaya Okura
Hiroyuki Hamakawa
Jingo Kusukawa
Iwai Tohnai

Purpose The purpose of this study was to assess the efficacy and safety of cetuximab plus platinum-based chemotherapy for patients specifically diagnosed with recurrent or metastatic oral squamous cell carcinoma (OSCC).

Keywords:

Cetuximab
Carcinoma
Cancer research
Pharmacology
Metastasis
Retrospective cohort study
Medicine
Chemotherapy
Cisplatin
Rash
Gastroenterology
Internal medicine
Carboplatin
Adverse effect
Leukopenia

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations